Trials / Unknown
UnknownNCT03182114
Supine Versus Left Lateral Tilted Position During Cesarean Delivery
Hemodynamic Effects of Supine Position Versus Left Lateral Tilted Position During Cesarean Delivery: a Randomized Controlled Trial.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
In this study, we will investigate the effect of left lateral tiling performed after spinal block on maternal hemodynamics compared to ordinary supine position
Detailed description
Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Aortocaval compression is one of the theoretical mechanisms precipitating for post-spinal hypotension (PSH) for CD. Positioning of the patients in the left lateral tilted position after preforming spinal block was frequently considered a standard protocol for minimizing aortocaval compression and improve maternal hemodynamics during CD; however, the latest Cochrane database review reported that there is no adequate evidence to support any positioning protocol for prevention of PSH. Moreover, a recent study was conducted in full term pregnant women reporting no improvement in cardiac output with left lateral tilting. In this study, the effect of left lateral tiling performed after spinal block on maternal hemodynamics will be compared to ordinary supine position.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | supine position | the patient will be placed in regular supine position after spinal anesthesia |
| OTHER | left lateral tilted position | the patient will be placed in left lateral tilted position after spinal anesthesia |
| DRUG | Bupivacaine | The patient will receive 10 mg Bupivacaine for spinal anesthesia |
Timeline
- Start date
- 2017-06-12
- Primary completion
- 2019-01-15
- Completion
- 2019-01-20
- First posted
- 2017-06-09
- Last updated
- 2018-07-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03182114. Inclusion in this directory is not an endorsement.